Clinical trial
SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
NCT00344994 · Augusta University, Other · Completed
Key facts
| NCT number | NCT00344994 |
|---|---|
| Title | SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole |
| Official title | An Open-Label Prospective Study of Restless Legs Patients Switched to Ropinirole From Pramipexole to Help Determine the Equipotent Dose |
| Lead sponsor | Augusta University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | pramipexole |
| Enrollment | 20 |
| Start date | May 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Apr 1, 2010 |
| First posted | Jun 27, 2006 |
| Last update posted | May 13, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: